Last quarter (Q3 2022), DocCheck AG's total revenue was €―, a decrease of ― from the same quarter last year. In Q3, DocCheck AG's net income was €―. See DocCheck AG’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 21	Dec 20	Dec 19	Dec 18	Dec 17
Total Revenue	-	€ 85.92M	€ 63.10M	€ 32.33M	€ 28.33M	€ 28.07M
Cost of Revenue	-	€ 42.43M	€ 27.96M	€ 9.81M	€ 8.80M	€ 9.15M
Gross Profit	-	€ 43.49M	€ 35.14M	€ 22.52M	€ 19.53M	€ 18.92M
Operating Expense	-	€ 27.13M	€ 21.84M	€ 18.26M	€ 16.26M	€ 15.44M
Operating Income	-	€ 16.36M	€ 13.30M	€ 4.25M	€ 3.27M	€ 3.47M
Net Non Operating Interest Income Expense	-	€ 588.90K	€ 95.30K	€ -2.30K	€ -403.06K	€ 13.14K
Other Income Expense	-	-	-	-	-	-
Pretax Income	-	€ 17.29M	€ 13.87M	€ 4.62M	€ 3.38M	€ 3.59M
Tax Provision	-	€ 5.46M	€ 4.26M	€ 1.52M	€ 1.16M	€ 1.19M
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	-	€ 11.40M	€ 9.20M	€ 3.14M	€ 2.27M	€ 2.41M
Basic EPS	-	€ 2.27	€ 1.83	€ 0.63	€ 0.46	€ 0.48
Diluted EPS	-	€ 2.25	€ 1.82	€ 0.63	€ 0.45	€ 0.48
Basic Average Shares	-	€ 5.03M	€ 5.03M	€ 4.99M	€ 4.99M	€ 4.99M
Diluted Average Shares	-	€ 5.07M	€ 5.05M	€ 5.02M	€ 5.02M	€ 5.02M
Dividend Per Share	-	€ 1.00	€ 0.10	€ 0.40	€ 0.40	€ 0.40
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	€ 568.00K	€ 352.00K	€ 396.00K	€ 1.17M	€ 928.00K
Total Expenses	-	€ 69.56M	€ 49.80M	€ 28.07M	€ 25.06M	€ 24.60M
Net Income From Continuing And Discontinued Operation	-	€ 11.40M	€ 9.20M	€ 3.14M	€ 2.27M	€ 2.41M
Normalized Income	-	€ 11.40M	€ 8.92M	€ 3.13M	€ 2.00M	€ 2.38M
Interest Expense	-	€ 243.93K	€ 192.34K	€ 275.76K	€ 417.97K	€ 133.83K
EBIT	-	€ 17.53M	€ 14.06M	€ 4.89M	€ 3.80M	€ 3.72M
EBITDA	-	€ 20.09M	€ 15.90M	€ 6.56M	€ 4.68M	€ 4.57M

Currency in EUR

DocCheck AG Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing